Home / Flurazepam / United States
US ATC N05CD01 · updated 2 Nov 2026
Flurazepam shortage in United States
Is there a Flurazepam shortage in United States?
Yes. As of 2 Nov 2026, 6 Flurazepam products are reported short in United States, the first since 3 Aug 2022. No return date has been given. Main reason: not stated.
Also short in Canada, Germany. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Chartwell Molecular Holdings LLC | 3 Aug 2022 | not given | Not stated |
| US | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Chartwell Molecular Holdings LLC | 3 Aug 2022 | not given | Not stated |
| US | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Chartwell Molecular Holdings LLC | 3 Aug 2022 | not given | Not stated |
| US | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Chartwell Molecular Holdings LLC | 3 Aug 2022 | not given | Not stated |
| US | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) anticipated | Rising Pharma Holdings, Inc. | 3 Aug 2022 | not given | Regulatory or licensing Regulatory delay |
| US | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) anticipated | Rising Pharma Holdings, Inc. | 3 Aug 2022 | not given | Regulatory or licensing Regulatory delay |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).